Clinical trial
Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With PAD and Claudication
NCT03457662 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With PAD and Claudication
- Lead sponsor
- First Affiliated Hospital of Harbin Medical University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 15, 2018
- Completion date
- April 11, 2019
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.